证券代码：688652 证券简称：京仪装备 公告编号：2025-027 北京京仪自动化装备技术股份有限公司 关于2025年半年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、计提减值准备的情况概述 北京京仪自动化装备技术股份有限公司(以下简称"公司")根据《企业会计准则第 8 号--资产减值》和相 关会计政策的规定，结合公司的实际情况，为客观、公允地反映公司截至2025年6月30日的财务状况和 2025年1-6月的经营成果，公司对截至2025年6月30日合并范围内存在减值迹象的资产进行了减值测试， 预计2025年1-6月公司计提各类信用减值损失及资产减值损失共计人民币25,114,381.71元，具体情况如 下： 单位：人民币元 ■ 二、计提减值准备事项的具体说明 （一） 信用减值损失 公司以预期信用损失为基础，对应收票据、应收账款、其他应收款进行了减值测试。经测试，本次需计 提信用减值损失金额共计13,459,607.14元。 （二） 资产减值损失 公司以预期信用损失为基础，对合同资产进行了 ...

Core Viewpoint - The report outlines the fundraising and usage status of Jiangsu Lian Ce Electromechanical Technology Co., Ltd. for the first half of 2025, confirming compliance with relevant regulations and detailing the management of raised funds [1][14]. Fundraising Basic Situation - The company raised a total of RMB 306.24 million through the issuance of 16 million shares at RMB 19.14 per share, with a net amount of RMB 252.07 million after deducting issuance costs [1]. - As of June 30, 2025, the company has a remaining balance of RMB 848,126.06 in the fundraising account [5][12]. Fundraising Management Situation - The company has established a fundraising management system to ensure proper use and storage of funds, including the establishment of special accounts for fundraising [3]. - The company signed tripartite and quadripartite supervision agreements with banks and sponsors to ensure compliance with fundraising regulations [4]. Actual Use of Fundraising - As of June 30, 2025, there were no abnormal situations in the use of funds for investment projects [6]. - The company did not engage in any early investment or replacement of fundraising projects during the reporting period [7][10]. - There were no instances of using idle funds to temporarily supplement working capital [8]. Cash Management of Idle Funds - The company approved the use of up to RMB 50 million of temporarily idle funds for cash management, with a total of RMB 11.83 million utilized for this purpose as of June 30, 2025 [9]. Remaining Fund Usage - The company permanently supplemented working capital with RMB 44.95 million of surplus funds from completed projects, with the remaining balance of RMB 848,126.06 still in the fundraising account [12][16]. Fund Usage and Disclosure Issues - The company has complied with all relevant regulations regarding the storage and actual use of fundraising, with no violations reported [14].

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the management of raised funds by Wuxi Dekeli Optoelectronic Technology Co., Ltd. It outlines the amounts raised, their usage, and compliance with regulatory requirements. Group 1: Fundraising Overview - The company raised a total of RMB 1,179,763,200.00 from its initial public offering (IPO) by issuing 24,320,000 shares at a price of RMB 48.51 per share, with a net amount of RMB 1,094,353,980.82 after deducting issuance costs [1][2] - In a subsequent offering, the company raised RMB 219,999,973.71 by issuing 3,464,021 shares at RMB 63.51 each, resulting in a net amount of RMB 217,149,951.88 after fees [2][30] Group 2: Fund Usage and Balances - As of June 30, 2025, the company has utilized RMB 526,762,655.47 from the IPO funds, leaving a balance of RMB 633,887,328.35 [2][3] - From the funds raised through the simplified procedure, RMB 105,386,112.54 has been used, with a remaining balance of RMB 117,280,466.63 [3] Group 3: Fund Management and Compliance - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts [4][31] - A tripartite agreement has been signed with the sponsor and the bank to regulate the management of the funds, ensuring investor protection [5][22] - The company has confirmed that there are no violations in the use of raised funds and has adhered to all disclosure requirements [17][37] Group 4: Cash Management - The company has approved the use of idle funds for cash management, allowing for investments in low-risk financial products, with a maximum of RMB 700 million allocated for such purposes [10][12] - As of June 30, 2025, the company had RMB 190 million in cash management products [12] Group 5: Project Implementation and Adjustments - There have been no changes in the implementation location or methods for the fundraising projects during the reporting period [13][16] - The company has approved extensions for certain fundraising project timelines, specifically for the "High-Speed Optical Module Production Line Expansion and Upgrade Project" [14]

经中国证券监督管理委员会证监许可〔2023〕887号《关于同意温州意华接插件股份有限公司向特定对 象发行股票注册的批复》同意，截至2024年3月27日，公司实际已发行人民币普通股（A股）16,567,996 股，发行价格32.19元/股，募集资金总额为533,323,791.24元，扣除保荐承销费用人民币11,792,452.83 元，减除其他与发行权益性证券直接相关的发行费用人民币722,233.96元，募集资金净额为人民币 520,809,104.45元，其中注册资本人民币16,567,996.00元，资本溢价人民币504,241,108.45元。上述资金 到位情况已经立信会计师事务所（特殊普通合伙）验证，并由其出具了"信会师报字[2024]第ZF10191 号"《验资报告》。 （二）募集资金使用情况及结余情况 截至2025年6月30日，募集资金使用情况及结余情况如下： 单位：人民币元 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002897 证券简称：意华股份 公告编号：2025-035 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根 ...

Group 1 - The company, Shandong Link Technology Co., Ltd., has completed its initial public offering (IPO) of 45,500,000 shares at a price of 14.27 RMB per share, raising a total of 649.29 million RMB, with a net amount of 596.31 million RMB after deducting issuance costs [2][3] - As of December 31, 2024, the cumulative amount used from the IPO funds is 570.41 million RMB, with an account balance of 40.64 million RMB remaining [2] - The company also issued 18,561,464 shares to specific investors at a price of 14.48 RMB per share, raising a total of 268.77 million RMB, with a net amount of 265.47 million RMB after costs [3] Group 2 - The company has established a fundraising management system to ensure the proper use and storage of raised funds, which are kept in dedicated bank accounts under a regulatory agreement [4][84] - As of June 30, 2025, the balance of the funds raised from the IPO is 29.83 million RMB, while the balance from the specific issuance is 18.11 million RMB [2][3] - The company has not changed any fundraising investment projects or transferred any investment projects to external parties [6] Group 3 - The board of directors has confirmed that there are no issues with the disclosure of fundraising usage information, ensuring that all disclosures are timely, truthful, accurate, and complete [6] - The company plans to hold its second extraordinary general meeting of 2025 on September 15, 2025, to discuss various matters, including the approval of the proposed guarantees for subsidiaries [24][28] Group 4 - The company has proposed a guarantee limit of up to 300 million RMB for its subsidiaries and 330 million RMB for inter-subsidiary guarantees for the year 2025 [61][76] - The board has assessed the financial health and creditworthiness of the subsidiaries involved in the guarantees, concluding that the risks are manageable [61][76]

公司代码：603190 公司简称：亚通精工 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到http://www.sse.com.cn网站仔细阅读半年度报告全文。 1.2本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.3公司全体董事出席董事会会议。 1.4本半年度报告未经审计。 1.5董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司拟向全体股东每10股派发现金红利0.6元（含税）。截至董事会审议利润分配预案日，公司总股本 12,000万股，以此计算合计拟派发现金红利720万元（含税），占公司2025年半年度归属于上市公司股 东净利润的比例为13.65%。剩余未分配利润滚存至下期，本次利润分配不送红股也不以资本公积金转 增股本。 如在本预案披露之日起至实施权益分派股权登记日期间，公司总股本发生变动的，公司拟维持每股分配 比例不变，相应调整分配总额。 第二节 公司基本情况 2.1公司简介 ■ 2.2主要财务数据 单位：元 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688261 证券简称：东微半导 公告编号：2025-039 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第1号——规范运 作》《上海证券交易所科创板股票上市规则》等有关法律、法规及相关文件的规定，苏州东微半导体股 份有限公司（以下简称"公司"）编制了《2025年半年度募集资金存放与实际使用情况的专项报告》，具 体内容如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意苏州东微半导体股份有限公司首次公开发行股票注册的批复》 （证监许可〔2021〕4040号），同意公司首次公开发行股票的注册申请。并经上海证券交易所同意，公 司首次向社会公众公开发行人民币普通股（A股）股票16,844,092股，本次发行价格为每股人民币130.00 元，募集资金总额为人民币2,189,731,960.00元，扣除保荐承销费155,127,216.60元（不 ...

Fundraising Overview - The company has been approved to issue convertible bonds totaling RMB 52 million, with a term of 6 years, and has successfully raised the full amount [2] - After deducting issuance costs of approximately RMB 7.11 million, the net amount raised is approximately RMB 51.29 million, which was fully received by July 8, 2024 [2] Fund Management - The company has established a fundraising management system in compliance with relevant regulations to protect the rights of small investors [3] - A tripartite supervision agreement has been signed with the project subsidiary and the sponsoring institution to ensure proper use of the raised funds [4][5] Special Account Management - The company has opened special accounts for the raised funds, with specific banks involved in the management of these accounts [6] - The company has decided to close the special accounts at two banks as the funds have been fully utilized, and the remaining interest will be transferred to the company's main account for working capital [8]

Core Viewpoint - Jiangsu Changqing Tree New Materials Technology Co., Ltd. reported its fundraising and usage situation for the first half of 2025, highlighting the total amount raised and the allocation of funds for various projects [2][3][4]. Group 1: Fundraising Overview - The company raised a total of RMB 125,067.72 million by issuing 48.14 million shares at a price of RMB 25.98 per share, with a net amount of RMB 113,222.81 million after deducting various fees [2][3]. - The funds were deposited into a dedicated account managed by the main underwriter, Everbright Securities Co., Ltd., on April 3, 2023 [2][3]. Group 2: Fund Usage and Balance - As of June 30, 2025, the company utilized RMB 16,437.49 million of the raised funds for investment projects, with a cumulative usage of RMB 54,705.11 million [3][4]. - The remaining balance of the raised funds was RMB 38,021.13 million, which includes bank interest and investment income [3][4]. Group 3: Fund Management - The company established a management system for the raised funds, ensuring they are stored in dedicated accounts and used in compliance with relevant regulations [4][5]. - A tripartite supervision agreement was signed with the underwriter and banks to ensure proper management of the funds [5]. Group 4: Adjustments to Fund Projects - In 2024, the company adjusted its fundraising investment projects, reducing the investment in certain facilities while increasing it in others, resulting in a net reduction of approximately RMB 3,000 million [14][15]. - The adjustments were made based on market conditions and operational needs, without changing the project name or implementation details [15]. Group 5: Operational Data - The company reported its main operational data for the first half of 2025, including production and sales figures, which reflect the company's performance in the new materials sector [25][26]. - The company noted that the sales volume exceeded production volume due to the purchase of finished products, specifically high polymer new material special monomers [25][26].

Core Viewpoint - The company, Zhejiang Ausun Pharmaceutical Co., Ltd., is preparing for its 2025 semi-annual performance briefing to provide investors with insights into its operational results and financial status for the first half of 2025 [6][7][10]. Company Overview - The company is identified by the stock code 603229 and is referred to as Ausun Pharmaceutical [5]. - The company has confirmed that all board members attended the board meeting [2]. Financial Data - The semi-annual report is unaudited [3]. - The company has not proposed any profit distribution or capital reserve conversion plans for the reporting period [4]. Important Matters - The company has indicated that there are no significant changes in its operational situation during the reporting period, nor any events that would have a major impact on its operations [4]. Investor Communication - The performance briefing is scheduled for September 9, 2025, from 15:00 to 16:00, and will be held at the Shanghai Stock Exchange Roadshow Center [6][8]. - Investors can submit questions for the briefing from September 2 to September 8, 2025, through the Roadshow Center's website or via email [6][9]. Fundraising and Usage - The company has conducted non-public stock offerings in 2020 and 2022, raising approximately RMB 420 million and RMB 485 million respectively, with net proceeds after expenses being RMB 408 million and RMB 474 million [11][12]. - As of June 30, 2025, the company has two fundraising special accounts for the 2020 offering and five for the 2022 offering [14][15]. - The company has utilized RMB 8 million of idle fundraising temporarily to supplement working capital, with RMB 6 million still outstanding as of June 30, 2025 [18][19]. - The company has not engaged in cash management or investment of idle funds during the reporting period [20]. Board and Supervisory Meetings - The fourth board meeting was held on August 28, 2025, where the semi-annual report and fundraising usage report were approved unanimously [36][39]. - The supervisory board also convened on the same day and approved the same reports, confirming their compliance with relevant laws and regulations [45][49].